‌

Primovist Regulatory Post Marketing Surveillance (PMS)

Overview Structured Data Issues Contributors

clinicaltrials.gov/study/NCT00924248

Is a

‌

Clinical study

Clinical Study attributes

NCT Number

NCT009242480

Health Conditions in Trial

Liver

Trial Recruitment Size

4,3580

Trial Sponsor

‌

Bayer

Clinical Trial Start Date

2007

Study Completion Date

2011

Clinical Trial Study Type

Observational0

Intervention Type

Drug0

Observational Clinical Trial Type

Cohort0

Observational Study Perspective

Prospective0

Official Name

Primovist Regulatory Post Marketing Surveillance0

Last Updated

September 19, 2012

Other attributes

Intervention Treatment

Gadoxetic acid disodium (Primovist, BAY86-4873)0

Study summary

The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like Primovist Regulatory Post Marketing Surveillance (PMS)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.